Lv41
550 积分 2021-03-02 加入
Discovery of Pyrazolo[1,5,4-de]quinoxalin-2(3H)-one Derivatives as Highly Potent and Selective PARP1 Inhibitors
5小时前
已完结
Targeting selective inhibitors of PARPs in drug discovery and development
1个月前
已完结
P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
1个月前
已关闭
Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers
1个月前
已完结
Targeted protein degradation: mechanisms, strategies and application
1个月前
已完结
Pyruvate kinase modulators as a therapy target: an updated patent review 2018-2023
2个月前
已完结
Pyruvate kinase modulators as a therapy target: an updated patent review 2018-2023
2个月前
已关闭
Design and evaluation of ZD06519, a novel camptothecin payload for antibody drug conjugates
2个月前
已完结
The CJEU abolishes Neurim and SPCs for new therapeutic indications
2个月前
已完结
Syrosingopine and UK5099 synergistically suppress non-small cell lung cancer by activating the integrated stress response
3个月前
已完结
皖公网安备34019202002308
